Luis A. Rojas

2.4k total citations
19 papers, 429 citations indexed

About

Luis A. Rojas is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Luis A. Rojas has authored 19 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Luis A. Rojas's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (9 papers) and RNA Interference and Gene Delivery (6 papers). Luis A. Rojas is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (9 papers) and RNA Interference and Gene Delivery (6 papers). Luis A. Rojas collaborates with scholars based in Spain, United States and Denmark. Luis A. Rojas's co-authors include Ramón Alemany, Rafael Moreno, Carlos Alberto Fajardo, Marcel Arias-Badia, Jana de Sostoa, Sònia Guedan, Carl H. June, António Figueras, Cristina Puig-Saus and Cristina Fillat and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Luis A. Rojas

18 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis A. Rojas Spain 12 250 238 210 72 47 19 429
Rita Sarkar United States 20 345 1.4× 722 3.0× 628 3.0× 63 0.9× 17 0.4× 31 1.1k
Elena Copreni Italy 14 116 0.5× 102 0.4× 281 1.3× 59 0.8× 8 0.2× 27 677
Firas Hamdan Finland 11 216 0.9× 93 0.4× 160 0.8× 171 2.4× 52 1.1× 20 453
Joung-Woo Choi South Korea 8 132 0.5× 235 1.0× 254 1.2× 24 0.3× 62 1.3× 8 392
Christianne Groeneveldt Netherlands 9 183 0.7× 110 0.5× 117 0.6× 141 2.0× 23 0.5× 14 321
Nicolas Boisgerault France 14 275 1.1× 343 1.4× 206 1.0× 201 2.8× 80 1.7× 25 688
Manlio Fusciello Finland 15 264 1.1× 183 0.8× 263 1.3× 236 3.3× 67 1.4× 25 564
Hexian Li China 12 234 0.9× 97 0.4× 124 0.6× 120 1.7× 30 0.6× 23 477
Ana F. Rodrigues Portugal 14 62 0.2× 255 1.1× 320 1.5× 53 0.7× 21 0.4× 26 466
Hoyin Mok United States 8 122 0.5× 318 1.3× 336 1.6× 42 0.6× 20 0.4× 10 465

Countries citing papers authored by Luis A. Rojas

Since Specialization
Citations

This map shows the geographic impact of Luis A. Rojas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis A. Rojas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis A. Rojas more than expected).

Fields of papers citing papers by Luis A. Rojas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis A. Rojas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis A. Rojas. The network helps show where Luis A. Rojas may publish in the future.

Co-authorship network of co-authors of Luis A. Rojas

This figure shows the co-authorship network connecting the top 25 collaborators of Luis A. Rojas. A scholar is included among the top collaborators of Luis A. Rojas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis A. Rojas. Luis A. Rojas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Balachandran, Vinod P., Luis A. Rojas, Zachary Sethna, et al.. (2022). Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 40(16_suppl). 2516–2516. 25 indexed citations
3.
Rojas, Luis A. & Vinod P. Balachandran. (2021). Scaling the immune incline in PDAC. Nature Reviews Gastroenterology & Hepatology. 18(7). 453–454. 13 indexed citations
4.
Mato-Berciano, Ana, Sara Morgado, María Victoria Maliandi, et al.. (2021). Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11. Journal of Controlled Release. 332. 517–528. 22 indexed citations
5.
Sendra, Luis, Marí­a José Herrero, Consuelo Cháfer‐Pericás, et al.. (2020). Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome. Nanomaterials. 10(6). 1183–1183. 10 indexed citations
6.
Moreno, Rafael, Carlos Alberto Fajardo, Marcel Arias-Badia, et al.. (2018). Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus. Molecular Therapy — Oncolytics. 8. 62–70. 15 indexed citations
7.
De, Pradip, Casey Williams, Luis A. Rojas, et al.. (2018). Abstract B092: Molecular aberrations of the PI3K-AKT-mTORC1/C2 pathway in ovarian cancers: a strategy for targeted therapy. Molecular Cancer Therapeutics. 17(1_Supplement). B092–B092. 1 indexed citations
8.
Fajardo, Carlos Alberto, Sònia Guedan, Luis A. Rojas, et al.. (2017). Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy. Cancer Research. 77(8). 2052–2063. 130 indexed citations
9.
Fajardo, Carlos Alberto, et al.. (2017). Arming oncolytic adenovirus with FAP-targeting bispecific T-cell engager to improve antitumor efficacy. Annals of Oncology. 28. xi18–xi18. 1 indexed citations
10.
González-Martı́n, Antonio, Luis A. Rojas, Patricia S. Braly, et al.. (2017). A randomized, double-blind, placebo-controlled multicenter phase 3 trial of niraparib maintenance treatment in patients with advanced ovarian cancer following frontline chemotherapy. Annals of Oncology. 28. v351–v351. 2 indexed citations
11.
Moreno, Rafael, Luis A. Rojas, F Vilardell, et al.. (2017). Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus. Stem Cells International. 2017. 1–10. 29 indexed citations
12.
Rojas, Luis A., Gabriela N. Condezo, Rafael Moreno, et al.. (2016). Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery. Journal of Controlled Release. 237. 78–88. 50 indexed citations
13.
Rojas, Luis A., Rafael Moreno, Hugo Calderón, & Ramón Alemany. (2016). Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction. Cancer Gene Therapy. 23(12). 411–414. 11 indexed citations
14.
Rodríguez-García, Alba, Erik Svensson, Carlos Alberto Fajardo, et al.. (2015). Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity. Gene Therapy. 22(7). 596–601. 16 indexed citations
15.
Agirre, Mireia, Jon Zárate Sesma, Edilberto Ojeda, et al.. (2014). Delivery of an adenovirus vector plasmid by ultrapure oligochitosan based polyplexes. International Journal of Pharmaceutics. 479(2). 312–319. 5 indexed citations
16.
17.
Rowan, Courtney M., et al.. (2013). Alteplase Use for Malfunctioning Central Venous Catheters Correlates With Catheter-Associated Bloodstream Infections. Pediatric Critical Care Medicine. 14(3). 306–309. 25 indexed citations
18.
19.
Rojas, Luis A., et al.. (2009). Prevalencia de la depresión infantil en Neiva (Colombia). SHILAP Revista de lepidopterología. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rita Sarkar Breakdown of academic impact, for papers by Elena Copreni Breakdown of academic impact, for papers by Firas Hamdan Breakdown of academic impact, for papers by Joung-Woo Choi Breakdown of academic impact, for papers by Christianne Groeneveldt Breakdown of academic impact, for papers by Nicolas Boisgerault Breakdown of academic impact, for papers by Manlio Fusciello Breakdown of academic impact, for papers by Hexian Li Breakdown of academic impact, for papers by Ana F. Rodrigues Breakdown of academic impact, for papers by Hoyin Mok
Rankless by CCL
2026